G

Genentech

Biotech firm creating medicines via R&D

Senior Principal Scientist - Pathologist

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • A DVM/VMD or equivalent veterinary degree and board certification by the American College of Veterinary Pathology (ACVP), European College of Veterinary Pathologists (ECVP), or an equivalent recognized board, with 5+ years of direct drug-development experience in the pharmaceutical or biotechnology industry and sufficient breadth and depth to independently support active programs from hire.
  • Ability to independently support and influence drug-development programs as a toxicologic pathologist, including interpreting nonclinical safety data in a broader translational and regulatory context.
  • A track record of effective cross-functional leadership and sound, risk-based decision making amid ambiguity, incomplete data, compressed timelines, or competing program priorities.
  • Strong knowledge of toxicologic pathology, nonclinical safety assessment, and principles underpinning regulatory toxicology and drug-development strategy.
  • Recognized expertise and demonstrated scientific leadership in at least one area relevant to translational safety, toxicologic pathology, or drug development.
  • Written and verbal communication skills to explain complex pathology and safety issues clearly to project teams, senior leaders, and regulatory audiences.
  • Ability and willingness to work on-site in South San Francisco at least 3 days per week.

Responsibilities

  • Serve as lead or project pathologist for multiple complex development programs and provide independent pathology strategy from discovery and candidate selection through regulatory milestones and later-stage development, as needed.
  • Provide expert veterinary, clinical, technical, and scientific input for studies, including necropsy, clinical pathology and histopathology interpretation, pathology peer review, and integrated assessment of study findings.
  • Partner with toxicologists, study operations professionals, translational scientists, pharmacologists, clinicians, and regulatory colleagues to design fit-for-purpose GLP and non-GLP safety programs that efficiently answer key development questions.
  • Synthesize complex or incomplete datasets, use external literature, and develop clear best-evidence positions supporting risk assessment, dose selection, study design, and program decisions.
  • Anticipate potential target-, modality-, or mechanism-related safety issues and design or lead investigative and mechanistic studies to resolve uncertainty and inform development strategy.
  • Contribute to and, where appropriate, lead development of safety biomarkers, diagnostics, digital or computational pathology approaches, and new approach methodologies (NAMs) that strengthen translation and decision making.
  • Identify opportunities to refine study design and reduce or replace animal use where scientifically appropriate while maintaining robust safety assessment and regulatory readiness.
  • Author or critically review regulatory documents and presentations; represent Translational Safety and Genentech/Roche in interactions with health authorities; and support programs using novel, accelerated, or otherwise nontraditional regulatory strategies.
  • Provide proactive scientific and strategic pathology leadership beyond assigned programs, including leading cross-functional initiatives, therapeutic-area or expert working groups, and functional capability-building efforts.
  • Mentor pathologists and other scientists, promote rigorous and pragmatic scientific decision making, and contribute to an inclusive, collaborative, high-performing team culture.
  • Advance the external scientific standing of Genentech/Roche through publications, presentations, scientific collaborations, and participation in relevant professional or industry forums.

Desired Qualifications

  • A PhD or equivalent advanced research training/experience in pathology or a related biomedical discipline.
  • Experience with, or strong scientific interest in, novel therapeutic modalities and their safety-assessment challenges.
  • Experience developing or applying new approach methodologies (NAMs), organotypic or in vitro models, computational or digital pathology approaches, or other innovative tools that improve human relevance and/or reduce animal use.
  • Commitment to animal welfare and the 3Rs (replacement, reduction, and refinement) in nonclinical development.
  • Drug-development experience across therapeutic areas or disease indications.
  • Direct experience with health-authority interactions, novel development pathways, or regulatory strategies requiring substantial scientific judgment and integration.
  • Evidence of scientific thought leadership through influential internal contributions, publications, presentations, professional society activity, or other recognized contributions to the field.

About the Company

Genentech

Biotech firm creating medicines via R&D

Genentech develops medicines and therapies to address unmet medical needs through extensive biotechnology research and development. Its products include biologic and small-molecule treatments prescribed by healthcare providers and sold through partnerships with suppliers and health systems. It differentiates itself with a large R&D footprint, a vast patent portfolio, and FDA Breakthrough Therapy Designations that accelerate promising therapies. Its goal is to advance medical science and deliver high-quality, effective therapies that improve patient health while supporting the broader medical community.

Company size
10,001+
Company stage
IPO
Headquarters
San Francisco, CA
Founded
1976

Recently Posted Jobs

Explore more opportunities at Genentech

See more jobs